PRJNA716141
Evaluation of mutations upon aquired Venetoclax or S63845 resistance
We generated cell lines with aquired Venetoclax (BCL2 inhibitor) or S63845 (MCL1 inhibitor) resistance and analysed aquired mutations by exom-seq.